Home > Insider Trading > Gossamer Bio Inc.

Gossamer Bio Inc. (GOSS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Gossamer Bio Completes Enrollment for Phase 3 PROSERA Study of PAH Drug Seralutinib

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best biotech stocks to invest in now. On June 16, Gossamer Bio announced the completion of enrollment for its global registrational Phase 3 PROSERA Study.

Keep Reading →

June 24th, 2025 - News

13 Best Biotech Stocks To Invest In Now

In 2023, the global biotechnology market size was estimated at $1.55 trillion.

Keep Reading →

June 24th, 2025 - News

Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the Gossamer Bio Q1 2025 Earnings Call.

Keep Reading →

May 17th, 2025 - News Transcripts

11 Best Penny Stocks to Invest in Under $1

Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, Gene Goldman, discussed how he thinks small-caps are a good investment.

Keep Reading →

April 15th, 2025 - Hedge Funds News

10 Stocks Under $10 that Will Triple

As we delve into the discussion on stocks that will triple, we must shed light on the U.S.

Keep Reading →

April 8th, 2025 - Hedge Funds News

12 Popular Penny Stocks on Robinhood to Watch

The stock market is navigating a complex landscape influenced by geopolitical tensions, trade policies, and shifting investor sentiments. Recent developments, such as the U.S.

Keep Reading →

March 23rd, 2025 - Hedge Funds News